Treatment Page 2 Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Safinamide improves the levodopa-based treatment of patients with Parkinson’s disease

Posted by on Nov 10, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of safinamide (Xadago) in the treatment of patients with Parkinson's disease in a real-life clinical practice. Researchers suggested that safinamide improves the outcomes of the treatment of these patients. Some background Parkinson's disease (PD) is a chronic disease that affects the...

Read More

Switching to an etanercept biosimilar – an investigation of the safety and efficacy profile

Posted by on Nov 10, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if switching from etanercept (Enbrel) to a biosimilar of etanercept (SDZ-ETN) is safe and effective in patients with rheumatoid arthritis (RA). They found that switching to SDZ-ETN from reference etanercept was safe and effective.  Some background Rheumatoid arthritis (RA) is a long-term...

Read More

Er:YAG laser – a treatment option for stress urinary incontinence in women?

Posted by on Nov 10, 2019 in Urinary incontinence | 0 comments

In a nutshell This study investigated the effects of Er:YAG laser treatment for mild and moderate stress urinary incontinence in women. The main finding was that the treatment appeared to improve the quality of life for patients with SUI. Some background Stress urinary incontinence (SUI) happens when an activity such as coughing, sneezing or...

Read More

Evaluating the effects of ranolazine, nicorandil and ivabradine in nonobstructive coronary artery disease

Posted by on Nov 10, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effects of ranolazine (Ranexa), nicorandil (Ikorel), and ivabradine (Corlanor) on angina. The main finding was that ranolazine and ivabradine reduced angina and nicorandil reduced microvascular resistance. Some background There are many drugs approved for the treatment of angina. These include ranolazine,...

Read More

Can dapagliflozin help improve blood magnesium levels in patients with Type 2 diabetes?

Posted by on Nov 6, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effects of dapagliflozin (Forxiga) on blood magnesium levels in patients with type 2 diabetes (T2D). The authors concluded that dapagliflozin treatment helped improve blood magnesium levels in these patients. Some background T2D is associated with a number of other health complications. Patients with T2D...

Read More

Is radiotherapy after chemotherapy associated with late side effects in patients with Hodgkin’s lymphoma?

Posted by on Nov 3, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the long-term outcomes of chemotherapy plus radiotherapy for patients with early-stage classical Hodgkin's lymphoma (cHL). The authors found that this treatment combination was highly effective, with minimal late side effects. Some background Early-stage (stage 1 to 2) cHL is usually treated with a...

Read More

Evaluating docetaxel plus hormone therapy for the treatment of metastatic prostate cancer

Posted by on Nov 3, 2019 in Prostate cancer | 0 comments

In a nutshell This study evaluated the long-term outcomes of docetaxel (Taxotere) plus hormone therapy for patients with metastatic prostate cancer (cancer that spread outside the prostate). This study found that this treatment combination improved survival for these patients, regardless of tumor burden. Some background One treatment for...

Read More